Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial

OBJECTIVE: This double-blind and randomized placebo-controlled trial evaluated the safety and efficacy of Danhong injection combined with Naoxintong capsule in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). METHODS: ACS patients scheduled to undergo PCI (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuai, Tang, Yong, Cai, Hairong, Liu, Weifeng, Zhang, Lieyuan, Chen, Dongjie, Chen, Bojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863299/
https://www.ncbi.nlm.nih.gov/pubmed/29707035
http://dx.doi.org/10.1155/2018/8485472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863299/
https://www.ncbi.nlm.nih.gov/pubmed/29707035
http://dx.doi.org/10.1155/2018/8485472

Ejemplares similares